000 01198 a2200349 4500
005 20250514012345.0
264 0 _c20011204
008 200112s 0 0 eng d
022 _a1094-5539
024 7 _a10.1006/pupt.2001.0305
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGroneberg, D A
245 0 0 _aEndogenous opioids as mediators of asthma.
_h[electronic resource]
260 _bPulmonary pharmacology & therapeutics
_c2001
300 _a383-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAsthma
_xphysiopathology
650 0 4 _aBronchoconstriction
650 0 4 _aHumans
650 0 4 _aInflammation
650 0 4 _aLung
_xinnervation
650 0 4 _aNeurons
_xphysiology
650 0 4 _aOligopeptides
_xpharmacology
650 0 4 _aOpioid Peptides
_xpharmacology
650 0 4 _aReceptors, Opioid
_xphysiology
650 0 4 _aSignal Transduction
650 0 4 _aNociceptin Receptor
650 0 4 _aNociceptin
700 1 _aFischer, A
773 0 _tPulmonary pharmacology & therapeutics
_gvol. 14
_gno. 5
_gp. 383-9
856 4 0 _uhttps://doi.org/10.1006/pupt.2001.0305
_zAvailable from publisher's website
999 _c11523566
_d11523566